Stopping after 30 days usually prevents you from reaching the phase where results accelerate
Currently: BPC-157 is not FDA-approved There are no standardized treatment guidelines Long-term human safety data is lacking Large randomized clinical trials have not been completed Optimal dosing protocols have not been established Because most published research comes from animal studies, scientists cannot yet determine whether the same effects occur in humans
When this barrier is compromised, undigested food particles, toxins, and bacterial byproducts can enter the bloodstream, contributing to inflammation and symptoms commonly associated with IBS, SIBO, and leaky gut
172 Hence, it seems likely that ghrelin induces glycogenolysis and/or inhibits glucose uptake into peripheral tissues from circulation via direct mechanisms
Administering IV drip therapy requires close supervision by a trained healthcare professional who can watch for side effects and make sure the patient is well-hydrated and electrolyte-balanced during the treatment